» Articles » PMID: 38270354

Contractile Properties and Magnetic Resonance Imaging-assessed Fat Replacement of Muscles in Myotonia Congenita

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2024 Jan 25
PMID 38270354
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Myotonia congenita (MC) is a muscle channelopathy in which pathogenic variants in a key sarcolemmal chloride channel Gene (CLCN1) cause myotonia. This study used muscle magnetic resonance imaging (MRI) to quantify contractile properties and fat replacement of muscles in a Danish cohort of MC patients.

Methods: Individuals with the Thomsen (dominant) and Becker (recessive) variants of MC were studied. Isometric muscle strength, whole-body MRI, and clinical data were collected. The degree of muscle fat replacement of thigh, calf, and forearm muscles was quantitively calculated on Dixon MRI as fat fractions (FFs). Contractility was evaluated as the muscle strength per contractile muscle cross-sectional area (PT/CCSA). Muscle contractility was compared with clinical data.

Results: Intramuscular FF was increased and contractility reduced in calf and in forearm muscles compared with controls (FF = 7.0-14.3% vs. 5.3-9.6%, PT/CCSA = 1.1-4.9 Nm/cm vs. 1.9-5.8 Nm/cm [p < 0.05]). Becker individuals also showed increased intramuscular FF and reduced contractility of thigh muscles (FF = 11.9% vs. 9.2%, PT/CCSA = 1.9 Nm/cm vs. 3.2 Nm/cm [p < 0.05]). Individual muscle analysis showed that increased FF was limited to seven of 18 examined muscles (p < 0.05). There was a weak correlation between reduced contractility and severity of symptoms.

Conclusions: Individuals with MC have increased fat replacement and reduced contractile properties of muscles. Nonetheless, changes were small and likely did not impact clinically on their myotonic symptoms.

Citing Articles

Contractile properties and magnetic resonance imaging-assessed fat replacement of muscles in myotonia congenita.

Jacobsen L, Stemmerik M, Skriver S, Pedersen J, Lokken N, Vissing J Eur J Neurol. 2024; 31(4):e16207.

PMID: 38270354 PMC: 11235747. DOI: 10.1111/ene.16207.

References
1.
Trip J, Pillen S, Faber C, van Engelen B, Zwarts M, Drost G . Muscle ultrasound measurements and functional muscle parameters in non-dystrophic myotonias suggest structural muscle changes. Neuromuscul Disord. 2009; 19(7):462-7. DOI: 10.1016/j.nmd.2009.06.369. View

2.
Lokken N, Hedermann G, Thomsen C, Vissing J . Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I. Ann Neurol. 2016; 80(3):466-71. DOI: 10.1002/ana.24743. View

3.
Kear B, Guck T, McGaha A . Timed Up and Go (TUG) Test: Normative Reference Values for Ages 20 to 59 Years and Relationships With Physical and Mental Health Risk Factors. J Prim Care Community Health. 2016; 8(1):9-13. PMC: 5932649. DOI: 10.1177/2150131916659282. View

4.
Sansone V, Ricci C, Montanari M, Apolone G, Rose M, Meola G . Measuring quality of life impairment in skeletal muscle channelopathies. Eur J Neurol. 2012; 19(11):1470-6. PMC: 3492909. DOI: 10.1111/j.1468-1331.2012.03751.x. View

5.
Vincent K, Carr A, Walburn J, Scott D, Rose M . Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology. 2007; 68(13):1051-7. DOI: 10.1212/01.wnl.0000257819.47628.41. View